|
Volumn 11, Issue 2, 2002, Pages 70-74
|
Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
COLLAGEN;
OXIDIZED CELLULOSE;
ARTICLE;
BANDAGE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DIABETIC FOOT;
ECONOMICS;
EUROPE;
FEMALE;
FOLLOW UP;
HEALTH CARE COST;
HOSPITALIZATION;
HUMAN;
MALE;
MULTICENTER STUDY;
NURSING;
PHYSIOLOGY;
PROBABILITY;
RANDOMIZED CONTROLLED TRIAL;
REFERENCE VALUE;
STATISTICS;
TREATMENT OUTCOME;
WOUND HEALING;
BANDAGES;
CELLULOSE, OXIDIZED;
COLLAGEN;
COST-BENEFIT ANALYSIS;
DIABETIC FOOT;
EUROPE;
FEMALE;
FOLLOW-UP STUDIES;
HEALTH CARE COSTS;
HUMANS;
MALE;
PROBABILITY;
REFERENCE VALUES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
WOUND HEALING;
|
EID: 0036482769
PISSN: 09690700
EISSN: None
Source Type: Journal
DOI: 10.12968/jowc.2002.11.2.26675 Document Type: Article |
Times cited : (78)
|
References (0)
|